Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving drugs in different ways may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of inhaled doxorubicin in treating patients
who have advanced solid tumors affecting the lungs.
Phase:
Phase 1
Details
Lead Sponsor:
National Institutes of Health Clinical Center (CC)